Executive SummaryThis report focuses is based on critical appraisal. This is the appraisal of the lab to market transition undertaken by one of the industry in the biotechnology field. Generally, it focuses on the commercialization process. This report also provides a synthesis of different elements involved in the commercialization process that concern the scientific R$D, business/product development, funding regimes and intellectual property strategies. The biotechnology industry under discussion is animal cloning. This is under scrutiny of USDA. USDA stands for United States of America Department of Agriculture. The innovative commercialization process here is the lab to market transition of animal cloning. IntroductionThe introduction focuses on the general case.
It also looks into history outline of the animal cloning industry, noteworthy developments and its growth over the years. Before talking of the transition however, looking into commercialization briefly is noteworthy. Commercialization entails the introduction of a new product into the market. It also involves introducing a new production method into the market. What is taking place in the company is a transition from the lab system to the market system. There is the introduction of the market system to replace the lab system.
The actual launch of the new product into the market acts as the final stage of the new product development. The company under discussion is an animal cloning company. Cloning falls under both biotechnology and technology. Cloning animals does not in any way require genetic modification like biotechnology. It leads to the production of twins and not altered animals. Animal clones begin their lives in the laboratory. This is where their embryos are implanted and later on born in the usual way. Invention and InnovationCloning is not new to people.
Plants have been cloned for many decades. However the process of cloning plants is called vegetative propagation. Most pears, peaches, potatoes, bananas, grapes and apples come from the cloning process. Livestock clowning originates from 1996. It has since then acted as the forward step in assisting with reproductive technology. This is the type of technology that has surpassed embryo transfer, in vitro fertilization and artificial insemination (E, 2000). Several other companies that deal with animal cloning have gone private. USDA has however not been involved heavily in scientific oversight of animal cloning.
It is necessary to clearly articulate strategic issues that the company has faced. This is in regard to commercialization process. Transition plan from lab to market is vital for the animal cloning company. Currently there are close to 600 animal clones. Most of them are beef cattle. It is however unlikely that they will head to the market. This is because they are highly expensive in production (Brizek, 2009). They are however being put to use as breeding livestock. They help in the transition of their exceptional qualities to their offspring.
Voluntary moratorium for any clones in the food supply is however continual. Opportunity RecognitionAny sexually reproduced offspring of any clones are animals that will end up winding up in the meat case or in producing milk in many dairy counters. The moratorium has therefore been lifted for any of these animals. The role of USDA therefore in the transition will be in facilitating smooth and orderly transition. This is helpful so that technology producers, providers, retailers, processors and international and domestic customers come together.
This way they can work together as milk and meat from animal clones and their own offspring’s become available in the market (Onyeka, 2011).